Neurofibromatosis: A common neurocutaneous disorder

被引:30
作者
Karnes, PS [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA
关键词
D O I
10.4065/73.11.1071
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neurofibromatosis (NF) type 1 (NF-1) is one of the most common of the neurocutaneous conditions, whereas NF type 2 (NF-2) accounts for an extremely small percentage of the total cases of NF, Indeed, most physicians will probably encounter at least one or two patients with NF-1 during the course of their practice. The manifestations can be varied and subtle; thus, the condition can sometimes be difficult to recognize, Nonetheless, the diagnosis of NF-1 is often clinically possible by the time the person is 10 years old, In this article, the diagnostic criteria for the most common types of NF are discussed, the common and some of the serious manifestations of both NF-1 and NF-2 are described, and suggestions for follow-up care are offered. Of importance, physicians must recognize that, although NF-1 and NF-2 share a common name, they are due to mutations in two different genes. Cure is not yet possible; thus, treatment is primarily symptomatic. A multidisciplinary treatment team is often helpful, particularly for patients with complicated problems.
引用
收藏
页码:1071 / 1076
页数:6
相关论文
共 56 条
[1]   NOONAN PHENOTYPE ASSOCIATED WITH NEUROFIBROMATOSIS [J].
ALLANSON, JE ;
HALL, JG ;
VANALLEN, MI .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1985, 21 (03) :457-462
[2]  
[Anonymous], 1988, Neurofibromatosis, V1, P172
[3]  
BADER J, 1987, DYSMORPHOL CLIN GENE, V1, P43
[4]   THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO MAMMALIAN GAP AND YEAST IRA PROTEINS [J].
BALLESTER, R ;
MARCHUK, D ;
BOGUSKI, M ;
SAULINO, A ;
LETCHER, R ;
WIGLER, M ;
COLLINS, F .
CELL, 1990, 63 (04) :851-859
[5]   ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715
[6]   BURKITT-LYMPHOMA IN A PATIENT WITH NEUROFIBROMATOSIS AND PHEOCHROMOCYTOMA [J].
BERMAN, BW ;
BINDER, RA ;
CORNFIELD, DB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 237 (10) :993-994
[7]   LENS OPACITIES IN NEUROFIBROMATOSIS-2 - FURTHER SIGNIFICANT CORRELATIONS [J].
BOUZAS, EA ;
FREIDLIN, V ;
PARRY, DM ;
ELDRIDGE, R ;
KAISERKUPFER, MI .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (06) :354-357
[8]  
CAMERON AJ, 1982, MAYO CLIN PROC, V57, P125
[9]  
CastanheiraDinis A, 1996, J NEURO-OPHTHALMOL, V16, P234
[10]   A MAJOR SEGMENT OF THE NEUROFIBROMATOSIS TYPE-1 GENE - CDNA SEQUENCE, GENOMIC STRUCTURE, AND POINT MUTATIONS [J].
CAWTHON, RM ;
WEISS, R ;
XU, GF ;
VISKOCHIL, D ;
CULVER, M ;
STEVENS, J ;
ROBERTSON, M ;
DUNN, D ;
GESTELAND, R ;
OCONNELL, P ;
WHITE, R .
CELL, 1990, 62 (01) :193-201